C. Rouzioux

发表

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

J. Chermann, F. Barré-Sinoussi, F. Rey, 1983, Science.

Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line

R. König, J. Gatot, C. Van Lint, 2016, Scientific Reports.

A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART

S. Granjeaud, D. Olive, C. Rouzioux, 2017, Front. Immunol..

NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147

S. Granjeaud, D. Olive, C. Rouzioux, 2017, Clinical & translational immunology.

Track A Basic Science

S. Sugden, D. Hazuda, F. Pereyra, 2012, Journal of the International AIDS Society.

Isolation of a new human retrovirus from West African patients with AIDS.

F. Brun-Vézinet, C. Katlama, S. Chamaret, 1986, Science.

Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study

Cyril Dalmasso, Laurence Meyer, Sigrid Le Clerc, 2008, PloS one.

Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.

Ilesh Jani, C. Rouzioux, A. Calmy, 2013, The Lancet. Infectious diseases.

Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study.

C. Rouzioux, M. Newell, S. Blanche, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia

C. Rouzioux, L. Ferradini, L. Pinoges, 2007, AIDS.

INFLUENZA BURDEN OF ILLNESS: ESTIMATES FROM A NATIONAL PROSPECTIVE SURVEY OF HOUSEHOLD CONTACTS IN FRANCE

Fabrice Carrat, F. Carrat, B. Housset, 2002, Archives of internal medicine.

Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens

C. Rouzioux, S. Blanche, P. Msellati, 2006, AIDS.

Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection

C. Rouzioux, J. Capeau, N. Dejucq-Rainsford, 2015, PLoS pathogens.

HIV Infection in the Native and Allograft Kidney: Implications for Management, Diagnosis, and Transplantation.

C. Rouzioux, G. Canaud, C. Legendre, 2017, Transplantation.

The kidney as a reservoir for HIV-1 after renal transplantation.

C. Rouzioux, O. Gribouval, C. Antignac, 2014, Journal of the American Society of Nephrology : JASN.

Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM Trial

C. Rouzioux, G. Chêne, G. Pialoux, 2012, AIDS.

Evaluation of an Upgraded Version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Test for HIV-1 Load Quantification

F. Brun-Vézinet, C. Rouzioux, D. Descamps, 2010, Journal of Clinical Microbiology.

Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV‐infected patients

C. Rouzioux, J. Delfraissy, F. Boufassa, 1994 .

Improved virological response to highly active antiretroviral therapy in HIV‐1‐infected patients carrying the CCR5 Δ32 deletion

C. Rouzioux, L. Meyer, J. Delfraissy, 2007, HIV medicine.

Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.

P. Debré, C. Rouzioux, L. Meyer, 1997, AIDS.

Comparative Assessment of Quantitative HIV Viraemia Assays

F. Brun-Vézinet, H. Agut, H. Fleury, 1992, AIDS.

Modeling SIV kinetics supports that cytotoxic response drives natural control and unravels heterogeneous populations of infected cells

C. Rouzioux, J. Guedj, C. Passaes, 2020, bioRxiv.

A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level

C. Rouzioux, L. Meyer, O. Lambotte, 2017, Open forum infectious diseases.

HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.

C. Rouzioux, P. Frange, G. Peytavin, 2016, The lancet. HIV.

Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients

C. Rouzioux, L. Meyer, O. Lambotte, 2014, AIDS.

Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers.

A. Bergamaschi, C. Rouzioux, O. Lambotte, 2011, Blood.

Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?

C. Rouzioux, L. Meyer, O. Lambotte, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cidofovir may be deleterious in BK virus-associated nephropathy.

C. Rouzioux, N. Pallet, E. Thervet, 2010, Transplantation.

Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?

R. Tubiana, L. Cravello, C. Rouzioux, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?

R. Tubiana, C. Rouzioux, L. Mandelbrot, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients

C. Fagard, C. Rouzioux, Y. Lévy, 2009, AIDS.

Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age.

C. Rouzioux, S. Blanche, F. Buseyne, 1998, Journal of Infectious Diseases.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

F. Dabis, C. Rouzioux, D. Ekouevi, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-1 infection in an individual homozygous for CCR5▵32

C. Katlama, C. Rouzioux, L. Meyer, 1997, The Lancet.

The measurement of HIV-1 viral load in resource-limited settings: how and where?

C. Rouzioux, F. Rouet, Christine Rouzioux, 2007, Clinical laboratory.

HIV-1 viral load testing cost in developing countries: what’s new?

C. Rouzioux, F. Rouet, 2007, Expert review of molecular diagnostics.

Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms.

F. Deist, C. Griscelli, C. Rouzioux, 1990, American journal of diseases of children.

Field Evaluation of an Improved Assay Using a Heat‐Dissociated p24 Antigen for Adults Mainly Infected With HIV‐1 CRF02_AG Strains in Côte d’Ivoire, West Africa

R. Salamon, F. Dabis, C. Rouzioux, 2003, Journal of acquired immune deficiency syndromes.

Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316.

R. Gelber, L. Mofenson, C. Rouzioux, 2002, The Journal of infectious diseases.

Appointment reminders to increase uptake of HIV retesting by at‐risk individuals: a randomized controlled study in Thailand

S. Chevret, C. Rouzioux, J. Mary, 2020, Journal of the International AIDS Society.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

R. Salamon, H. Ahiboh, C. Rouzioux, 2015, The New England journal of medicine.

A Prospective Study of Infants Born to Women Seropositive for Human Immunodeficiency Virus Type I

F. Deist, C. Griscelli, C. Rouzioux, 1990 .

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

P. Rustin, A. Rötig, C. Lacroix, 1999, The Lancet.

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial

R. Salamon, F. Dabis, C. Rouzioux, 1999, The Lancet.

Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission.

C. Rouzioux, P. Jouannet, E. Dulioust, 1999, AIDS.

Influenza and influenza-like illness in general practice: drawing lessons for surveillance from a pilot study in Paris, France.

F. Carrat, A. Valleron, B. Housset, 1997, The British journal of general practice : the journal of the Royal College of General Practitioners.

Stimulation of the primary anti‐HIV antibody response by IFN‐α in patients with acute HIV‐1 infection

C. Rouzioux, P. Poignard, P. Lebon, 2008, Journal of leukocyte biology.

Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy

C. Rouzioux, S. Pol, H. Fontaine, 2006, AIDS.

Detection of hepatitis C virus in the semen of infected men

C. Rouzioux, M. Chaix, M. Leruez-Ville, 2000, The Lancet.

Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study.

C. Rouzioux, D. Scott‐Algara, T. Montange, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study.

C. Rouzioux, D. Scott‐Algara, C. Dollfus, 2012, The Journal of infectious diseases.

Mother-to-child transmission of HIV-2 infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO1.

C. Rouzioux, S. Blanche, J. Warszawski, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10).

C. Rouzioux, C. Dollfus, S. Blanche, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increase in hepatitis C virus incidence in HIV-1-infected patients followed up since primary infection

C. Rouzioux, L. Meyer, Z. Nagy, 2006, Sexually Transmitted Infections.

Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.

B. Masquelier, F. Dabis, C. Rouzioux, 2007, International journal of epidemiology.

French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults

C. Delaugerre, P. Morlat, C. Rouzioux, 2014, Journal of the International AIDS Society.

MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infection

A. Samri, B. Autran, C. Rouzioux, 2013, AIDS.

mulTI-cohorT GeneTIc assocIaTIon sTudy reVeals cXcr 6 as a new chemokIne recePTor InVolVed In aIds lonG-Term non-ProGressIon

Serge, O. Delaneau, J. Goedert, 2011 .

Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method.

C. Rouzioux, D. Costagliola, M. Burgard, 1997, AIDS.

DETECTION OF HTV1 DNA IN INFANTS AND CHILDREN BY MEANS OF THE POLYMERASE CHAIN REACTION

C. Griscelli, C. Rouzioux, C. Bréchot, 1988, The Lancet.

Varicella and zoster in children after kidney transplantation: long-term results of vaccination.

C. Rouzioux, G. Guest, M. Broyer, 1997, Pediatrics.

Interruption of cART in Clinical Practice Is Associated With an Increase in the Long-Term Risk of Subsequent Immunosuppression in HIV-1-Infected Children

C. Rouzioux, C. Dollfus, S. Blanche, 2014, The Pediatric infectious disease journal.

Ultrasensitive Detection of p24 in Plasma Samples from People with Primary and Chronic HIV-1 Infection

C. Delaugerre, C. Rouzioux, D. Duffy, 2021, Journal of virology.

Monitoring Cytomegalovirus Infection in Adult and Pediatric Bone Marrow Transplant Recipients by a Real-Time PCR Assay Performed with Blood Plasma

C. Rouzioux, S. Blanche, A. Buzyn, 2003, Journal of Clinical Microbiology.

HHV‐6 and EBV DNA quantitation in lymph nodes of 86 patients with Hodgkin's lymphoma

C. Rouzioux, B. Petit, A. Jaccard, 2007, Journal of medical virology.

Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset

F. Barré-Sinoussi, C. Rouzioux, P. Roques, 2016, PLoS pathogens.

CCR5 D32 Deletion and Reduced Risk of Toxoplasmosis in Persons Infected with Human Immunodeficiency Virus Type 1

P. Debré, C. Rouzioux, L. Meyer, 1999 .

CCR5 Δ32 Deletion and Reduced Risk of Toxoplasmosis in Persons Infected with Human Immunodeficiency Virus Type 1

P. Debré, C. Rouzioux, L. Meyer, 1999 .

CONCISE COMMUNICATIONS CCR5 D32 Deletion and Reduced Risk of Toxoplasmosis in Persons Infected with Human Immunodeficiency Virus Type 1

P. Debré, C. Rouzioux, L. Meyer, 1999 .

Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers

C. Rouzioux, H. Mouquet, O. Schwartz, 2022, Nature communications.

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

D. Richman, J. Martinez-Picado, C. Katlama, 2013, The Lancet.

Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France.

A. Berrebi, C. Rouzioux, L. Mandelbrot, 1997, The Journal of pediatrics.

Multicenter Quality Control for the Detection of Hepatitis C Virus RNA in Seminal Plasma Specimens

J. Pawlotsky, C. Rouzioux, S. Laporte, 2003, Journal of Clinical Microbiology.

Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects.

C. Rouzioux, C. Bréchot, S. Pol, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study

M. Jauffret-Roustide, C. Rouzioux, P. Chauvin, 2020, BMC Infectious Diseases.

Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Speciﬁc CD8 (cid:2) T Cell Response in HIV Controllers

C. Rouzioux, L. Meyer, O. Lambotte, 2013 .

Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery

C. Griscelli, C. Rouzioux, F. Monpoux, 1994, The New England journal of medicine.

Mother-to-Child Transmission of HIV-2 Infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO 1

C. Rouzioux, L. Mandelbrot, S. Blanche, 2010 .

18-Month Effectiveness of Short-Course Antiretroviral Regimens Combined with Alternatives to Breastfeeding to Prevent HIV Mother-to-Child Transmission

F. Dabis, C. Rouzioux, L. Dequae-Merchadou, 2008, PloS one.

Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial

F. Dabis, C. Rouzioux, P. Van de Perre, 2001, AIDS.

The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates

C. Griscelli, C. Rouzioux, S. Blanche, 1992, The New England journal of medicine.

Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers

B. Autran, C. Rouzioux, A. Kirilovsky, 2014, AIDS.

Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study

M. Lederman, R. Sékaly, J. Routy, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association Between Medication Possession Ratio, Virologic Failure and Drug Resistance in HIV-1–Infected Adults on Antiretroviral Therapy in Côte d'Ivoire

K. Freedberg, E. Losina, C. Rouzioux, 2011, Journal of acquired immune deficiency syndromes.

A virologic survey of patients admitted to a critical care unit for acute cardiorespiratory failure

F. Carrat, C. Rouzioux, E. Maury, 2005, Intensive Care Medicine.

Mortality Among HIV-1-Infected Women According to Children's Feeding Modality: An Individual Patient Data Meta-Analysis

Leroy, W. Willett, W. Fawzi, 2005, Journal of acquired immune deficiency syndromes.

Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion.

C. Rouzioux, A. Sáez-Cirión, L. Hocqueloux, 2013, JAMA internal medicine.

CCR2B-64I Chemokine Receptor Allele and Mother-to-Child HIV-1 Transmission or Disease Progression in Children

C. Rouzioux, S. Blanche, J. Delfraissy, 1999 .

CCR2B-64I chemokine receptor allele and mother-to-child HIV-1 transmission or disease progression in children. French pediatric HIV infection study group.

C. Rouzioux, S. Blanche, J. Delfraissy, 1999, Journal of acquired immune deficiency syndromes.

Early protective effect of CCR‐5 Δ32 heterozygosity on HIV‐1 disease progression: relationship with viral load

P. Debré, C. Rouzioux, L. Meyer, 1997 .

CD4 percentages and total lymphocyte counts as early surrogate markers for pediatric HIV-1 infection in resource-limited settings.

F. Dabis, C. Rouzioux, D. Ekouevi, 2006, Journal of tropical pediatrics.

DIAGNOSIS OF TOXOPLASMA ENCEPHALITIS IN ABSENCE OF NEUROLOGICAL SIGNS BY EARLY COMPUTERISED TOMOGRAPHIC SCANNING IN PATIENTS WITH AIDS

E. Denamur, F. Barré-Sinoussi, C. Rouzioux, 1984, The Lancet.

Lung in acquired immune deficiency syndrome: infectious and immunological status assessed by bronchoalveolar lavage.

C. Rouzioux, B. Régnier, F. Clavel, 1985, Bulletin europeen de physiopathologie respiratoire.

Increasing Rate of TAMs and Etravirine Resistance in HIV-1–Infected Adults Between 12 and 24 Months of Treatment: The VOLTART Cohort Study in Côte d’Ivoire, West Africa

C. Rouzioux, S. Eholie, A. Minga, 2013, Journal of acquired immune deficiency syndromes.

Novel role of UHRF1 in the epigenetic repression of the latent HIV-1

B. Berkhout, C. Van Lint, C. Rouzioux, 2022, EBioMedicine.

Gag-specific CD8 T-cell proliferation is associated with higher peripheral blood levels of TGF- β and gut-homing T cells in youths perinatally infected with HIV-1 – The ANRS- EP38-IMMIP Study

C. Rouzioux, T. Montange, C. Dollfus, 2018 .

Gag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-β and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP Study

C. Rouzioux, D. Scott‐Algara, T. Montange, 2016, Open forum infectious diseases.

High risk of HIV disease progression after infection through a sexual partner with AIDS

C. Rouzioux, L. Meyer, F. Boufassa, 1996, AIDS.

Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection

C. Delaugerre, C. Rouzioux, L. Meyer, 2018, The Journal of infectious diseases.

0.1. Association of plasma sVCAM-1 and sCD14 with mortality in HIV-1 infected West African adults with high CD4 counts.

C. Rouzioux, S. Eholie, C. Dunyach-Rémy, 2020, Journal of acquired immune deficiency syndromes.

Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men

C. Katlama, C. Rouzioux, J. Bresson, 2004, AIDS.

Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?

R. Tubiana, C. Rouzioux, L. Mandelbrot, 2008, AIDS.

HIV-1 RNA detection in plasma for the diagnosis of infection in neonates. The French Pediatric HIV Infection Study Group.

C. Rouzioux, S. Blanche, M. Chaix, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Impact of early cART on HIV blood and semen compartments at the time of primary infection

C. Rouzioux, J. Heitzmann, M. Müller-Trutwin, 2017, PloS one.

Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3

B. Berkhout, C. Van Lint, C. Rouzioux, 2018, mBio.

Effect of perinatal zidovudine prophylaxis on the evolution of cell-free HIV-1 RNA in breast milk and on postnatal transmission.

F. Dabis, C. Rouzioux, P. Van de Perre, 2004, The Journal of infectious diseases.

Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers.

C. Rouzioux, L. Mandelbrot, S. Blanche, 1999, AIDS.

No detection of HIV 1-RNA in semen of men on efficient HAART in the past 4 years of a 2002–2009 survey

C. Rouzioux, P. Jouannet, P. Sogni, 2010, AIDS.

Timing of mother‐to‐child HIV‐1 transmission depends on maternal status

A. Valleron, C. Griscelli, C. Rouzioux, 1993, AIDS.

Barriers to a Cure: New concepts in targeting and eradicating HIV-1 reservoirs

Jeffrey, D. Richman, J. Martinez-Picado, 2013 .

Population Analysis of Weight-, Age-, and Sex-Related Differences in the Pharmacokinetics of Lopinavir in Children from Birth to 18 Years

C. Delaugerre, C. Rouzioux, S. Urien, 2006, Antimicrobial Agents and Chemotherapy.

Reply to Spellberg

B. Autran, C. Rouzioux, Nicole N’Go-Giang-Huong, 2006 .

Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction

C. Rouzioux, J. Huraux, J. Aubin, 1991, Journal of clinical microbiology.

Long-Term HIV-1 Virologic Control in Patients on a Dual NRTI Regimen

C. Rouzioux, L. Hocqueloux, D. Zucman, 2013, HIV clinical trials.

Molecular identification of viruses in sudden infant death associated with myocarditis and pericarditis.

C. Rouzioux, J. Burns, G. Stanway, 1995, The Pediatric infectious disease journal.

No association between human herpesvirus 6 reactivation and cryptococcosis in human immunodeficiency virus-infected patients.

C. Rouzioux, L. Ferradini, P. Buchy, 2009, Journal of Medical Microbiology.

Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) Study.

C. Rouzioux, G. Chêne, J. Molina, 2001, AIDS.

Comparison of Early CD4 T-Cell Count in HIV-1 Seroconverters in Côte d'Ivoire and France: The ANRS PRIMO-CI and SEROCO Cohorts

C. Rouzioux, L. Meyer, A. Minga, 2010, Journal of acquired immune deficiency syndromes.

Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies.

A. Fischer, C. Rouzioux, P. Frange, 2012, The Journal of infectious diseases.

LTR Real-Time PCR for HIV-1 DNA Quantitation in Blood Cells for Early Diagnosis in Infants Born to Seropositive Mothers Treated in HAART Area ( ANRS CO 01 )

C. Rouzioux, S. Blanche, J. Warszawski, 2008 .

Impact of HIV-1 Genetic Diversity on Plasma HIV-1 RNA Quantification: Usefulness of the Agence Nationale de Recherches sur le SIDA Second-Generation Long Terminal Repeat-Based Real-Time Reverse Transcriptase Polymerase Chain Reaction Test

M. Peeters, C. Rouzioux, L. Ferradini, 2007, Journal of acquired immune deficiency syndromes.

Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts

C. Rouzioux, S. Eholie, X. Anglaret, 2020, EBioMedicine.

Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains.

C. Rouzioux, L. Meyer, N. Lerolle, 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Quantification of total HIV1-DNA in peripheral blood mononuclear cells.

C. Rouzioux, A. Mélard, V. Avettand-Fenoël, 2014, Methods in molecular biology.

Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis.

C. Rouzioux, S. Blanche, N. Ciraru‐Vigneron, 2012, The Journal of pediatrics.

Undetectable HIV‐1 RNA load with the Cobas TaqMan v1.0 in a patient diagnosed at the time of primary HIV‐1 infection

C. Rouzioux, L. Meyer, D. Descamps, 2010, Journal of medical virology.

HBV and HCV prevalence and viraemia in HIV‐positive and HIV‐negative pregnant women in Abidjan, Côte d'Ivoire: The ANRS 1236 study

F. Dabis, C. Rouzioux, P. Msellati, 2004, Journal of medical virology.

HIV mediated immune aging in young adults infected perinatally or during childhood.

V. Appay, C. Rouzioux, C. Vigouroux, 2019, AIDS.

Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1.

C. Rouzioux, F. Monpoux, M. Tardieu, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

How to best measure HIV reservoirs?

D. Richman, C. Rouzioux, 2013, Current opinion in HIV and AIDS.

CCR5 antagonists: a therapeutic option in HIV-1 perinatally infected children experiencing virologic failure?

C. Rouzioux, P. Frange, S. Blanche, 2012, AIDS.

Assisted reproduction in HIV-1-serodifferent couples: the need for viral validation of processed semen

C. Rouzioux, L. Mandelbrot, P. Jouannet, 2002, AIDS.

Semen alterations in HIV-1 infected men.

C. Rouzioux, D. Costagliola, L. Mandelbrot, 2002, Human reproduction.

No relation between in-utero exposure to HAART and intrauterine growth retardation

R. Tubiana, C. Rouzioux, L. Mandelbrot, 2009, AIDS.

HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group.

C. Katlama, C. Rouzioux, L. Meyer, 1997, Lancet.

Separation between HIV-positive women and their children: the French prospective study, 1986 through 1993.

C. Rouzioux, G. Noseda, S. Blanche, 1996, American journal of public health.

No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.

A. Berrebi, R. Tubiana, C. Rouzioux, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study

R. Tubiana, C. Rouzioux, P. Frange, 2022, The Journal of antimicrobial chemotherapy.

Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings.

J. Stringer, F. Dabis, C. Rouzioux, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acute HIV infection after acupuncture treatments.

C. Rouzioux, J. Bach, D. Vittecoq, 1989, The New England journal of medicine.

Comments on "cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection".

Y. Ville, C. Rouzioux, M. Chaix, 2007, The Journal of infectious diseases.

Non-Disclosure of a Pregnant Woman’s HIV Status to Her Partner is Associated with Non-Optimal Prevention of Mother-to-Child Transmission

R. Tubiana, C. Rouzioux, L. Mandelbrot, 2013, AIDS and Behavior.

Description of an adenovirus A31 outbreak in a paediatric haematology unit

C. Rouzioux, B. Neven, S. Blanche, 2006, Bone Marrow Transplantation.

ABSENCE OF ANTIBODIES TO AIDS VIRUS IN HAEMOPHILIACS TREATED WITH HEAT-TREATED FACTOR VIII CONCENTRATE

S. Chamaret, C. Rouzioux, L. Montagnier, 1985, The Lancet.

ISOLATION OF NEW LYMPHOTROPIC RETROVIRUS FROM TWO SIBLINGS WITH HAEMOPHILIA B, ONE WITH AIDS

A. Fischer, C. Griscelli, J. Chermann, 1984, The Lancet.

Immunoglobulin G antibodies to lymphadenopathy-associated virus in differently treated French and Belgian hemophiliacs.

F. Brun-Vézinet, C. Rouzioux, D. Klatzmann, 1985, Annals of internal medicine.

Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection.

C. Rouzioux, L. Meyer, J. Guillet, 1999, The Journal of clinical investigation.

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

J L Sullivan, R. Gelber, S. Spector, 1996, The New England journal of medicine.

The HIV RNA setpoint theory revisited

Ben Berkhout, Ronald B Geskus, Laurence Meyer, 2007, Retrovirology.

Hepatitis C virus in the semen of men coinfected with HIV-1: prevalence and origin

C. Rouzioux, S. Pol, P. Jouannet, 2005, AIDS.

Sexually transmitted hepatitis C virus superinfection in HIV/hepatitis C virus co-infected men who have sex with men

C. Delaugerre, C. Rouzioux, S. Pol, 2008, AIDS.

Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals

C. Rouzioux, M. Kazatchkine, Y. Lévy, 2006, AIDS.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

GRANULOCYTE-ASSOCIATED IMMUNOGLOBULINS IN RENAL TRANSPLANT RECIPIENTS WITH CYTOMEGALOVIRUS INFECTION

C. Rouzioux, P. Berche, J. Cartron, 1988, The Lancet.

Detection of HIV-1 in seminal plasma and seminal cells of HIV-1 seropositive men.

C. Rouzioux, P. Jouannet, E. Dulioust, 1998, Journal of reproductive immunology.

Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases.

F. Brun-Vézinet, J. Lifson, J. Chermann, 1986, The American journal of medicine.

ISOLATION OF HUMAN T-LYMPHOTROPIC RETROVIRUS (LAV) FROM ZAIRIAN MARRIED COUPLE, ONE WITH AIDS, ONE WITH PRODROMES

F. Brun-Vézinet, J. Chermann, F. Rey, 1984, The Lancet.

CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group.

C. Rouzioux, S. Blanche, J. Delfraissy, 1998, JAMA.

HIV type 1-infected dendritic cells induce apoptotic death in infected and uninfected primary CD4 T lymphocytes.

P. Vidalain, C. Rabourdin-Combe, C. Rouzioux, 2004, AIDS research and human retroviruses.

DETECTION OF IgG ANTIBODIES TO LYMPHADENOPATHY-ASSOCIATED VIRUS IN PATIENTS WITH AIDS OR LYMPHADENOPATHY SYNDROME

F. Brun-Vézinet, J. Chermann, F. Barré-Sinoussi, 1984, The Lancet.

A prospective study of infants born to women seropositive for human immunodeficiency virus type 1.

C. Griscelli, C. Rouzioux, S. Blanche, 1989 .

Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults.

R. Salamon, C. Rouzioux, E. Bissagnéné, 2009, The Journal of infectious diseases.

Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy.

C. Rouzioux, L. Mandelbrot, S. Blanche, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.

C. Griscelli, J. Chermann, F. Barré-Sinoussi, 1984, Science.

Cerebral venous thrombosis and dual primary infection with human immunodeficiency virus and cytomegalovirus.

C. Rouzioux, E. Roullet, A. Aymard, 1989, Journal of neurology, neurosurgery, and psychiatry.

Quantitation of HIV-1 RNA in breast milk by real time PCR.

C. Rouzioux, P. Van de Perre, V. Foulongne, 2006, Journal of virological methods.

Lymphadenopathy-associated virus isolated from bronchoalveolar lavage fluid in AIDS-related complex with lymphoid interstitial pneumonitis.

F. Brun-Vézinet, J. Chermann, F. Barré-Sinoussi, 1985, The New England journal of medicine.

Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study: 7 years of follow-up observation. The French Pediatric HIV Infection Study Group.

C. Rouzioux, S. Blanche, M. Mayaux, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.

R. Salamon, C. Rouzioux, S. Eholie, 2017, The Lancet. Global health.

Amniocentesis and mother-to-child human immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales French Perinatal Cohort.

R. Tubiana, C. Rouzioux, L. Mandelbrot, 2009, American journal of obstetrics and gynecology.

A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir

C. Rouzioux, D. Costagliola, A. Mélard, 2010, Journal of Medical Virology.

Prevention of Maternal HIV Transmission

C. Rouzioux, 2012, Drugs.

Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children.

C. Rouzioux, A. Kpozèhouen, S. Blanche, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Change to a Once-Daily Combination Including Boosted Atazanavir in HIV-1-Infected Children

C. Delaugerre, C. Rouzioux, S. Blanche, 2006, The Pediatric infectious disease journal.

Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship

C. Rouzioux, A. Calmy, I. Jani, 2014, The Journal of antimicrobial chemotherapy.

Relationship of CD4+ T-cell counts and plasma HIV-1 RNA levels with serological HBeAg/anti-HBe patterns obtained in West-African HBV-HIV-1-co-infected children.

C. Rouzioux, A. Kpozèhouen, S. Blanche, 2009, Journal of tropical pediatrics.

Prevalence, Risk Factors, and Impact on Outcome of Cytomegalovirus Replication in Serum of Cambodian HIV-Infected Patients (2004-2007)

C. Rouzioux, L. Ferradini, P. Buchy, 2009, Journal of acquired immune deficiency syndromes.

Early assessment of antiretroviral efficacy is critical to prevent the emergence of resistance mutations in HIV-tuberculosis coinfected patients: a substudy of the CARINEMO-ANRS12146 trial

C. Rouzioux, A. Calmy, I. Jani, 2019, F1000Research.

Randomized study of two doses of didanosine in children infected with human immunodeficiency virus.

C. Rouzioux, D. Costagliola, S. Blanche, 1993, The Journal of pediatrics.

Emtricitabine Seminal Plasma and Blood Plasma Population Pharmacokinetics in HIV-Infected Men in the EVARIST ANRS-EP 49 Study

C. Rouzioux, S. Urien, M. Suzan-Monti, 2015, Antimicrobial Agents and Chemotherapy.

Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group.

A. Valleron, C. Griscelli, C. Rouzioux, 1995, American journal of epidemiology.

Herpesvirus infection of the respiratory tract in patients with alcoholic hepatitis.

C. Rouzioux, C. Degott, F. Durand, 1992, Alcoholism, clinical and experimental research.

Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: A case‐controlled study

C. Rouzioux, C. Legendre, A. Ferroni, 1993, Journal of medical virology.

Human Cytomegalovirus UL144 Gene Polymorphisms in Congenital Infections

Y. Ville, C. Rouzioux, M. Chaix, 2005, Journal of Clinical Microbiology.

A prospective study of infants born to women seropositive for human immunodeficiency virus type 1

C. Griscelli, C. Rouzioux, S. Blanche, 1990, The New England journal of medicine.

Relationship between antiretroviral drug plasma concentrations and viral load in children.

C. Rouzioux, P. Quartier, S. Blanche, 2003, Journal of acquired immune deficiency syndromes.

Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting

Xavier Anglaret, F. Dabis, C. Rouzioux, 2005, Journal of Clinical Microbiology.

Screening for lymphadenopathy/AIDS virus in bone marrow-transplant recipients.

J. Chermann, C. Rouzioux, L. Montagnier, 1986, The New England journal of medicine.

Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort

R. Tubiana, C. Rouzioux, L. Mandelbrot, 2008, AIDS.

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

A. Berrebi, C. Rouzioux, L. Mandelbrot, 2001, JAMA.

Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy

C. Rouzioux, L. Meyer, J. Molina, 2015, AIDS.

CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients.

P. Debré, C. Rouzioux, L. Meyer, 2000, AIDS.

Longitudinal comparison of HIV-1 RNA burden in plasma and cerebrospinal fluid in two patients starting triple combination antiretroviral therapy.

C. Rouzioux, G. Peytavin, C. Rabian, 1998, AIDS.

Lopinavir/Ritonavir-based Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-infected Naive Children: Rare Protease Inhibitor Resistance Mutations But High Lamivudine/Emtricitabine Resistance at the Time of Virologic Failure

C. Rouzioux, N. Mahlaoui, P. Frange, 2011, The Pediatric infectious disease journal.

Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure

C. Rouzioux, I. Jani, S. Blanche, 2009, The Pediatric infectious disease journal.

Genotypic Human Immunodeficiency Virus Type 1 Drug Resistance in Highly Active Antiretroviral Therapy-Treated Children in Abidjan, Côte d'Ivoire

C. Rouzioux, S. Blanche, P. Msellati, 2005, The Pediatric infectious disease journal.

Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance

F. Dabis, C. Rouzioux, G. Gray, 2010, AIDS.

Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.

F. Dabis, C. Rouzioux, G. Gray, 2009, AIDS.

Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire.

F. Dabis, C. Rouzioux, G. Peytavin, 2006, The Journal of infectious diseases.

Impact of Nevirapine (NVP) Plasma Concentration on Selection of Resistant Virus in Mothers Who Received Single-Dose NVP To Prevent Perinatal Human Immunodeficiency Virus Type 1 Transmission and Persistence of Resistant Virus in Their Infected Children

F. Dabis, C. Rouzioux, G. Peytavin, 2006, Antimicrobial Agents and Chemotherapy.

Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications

C. Rouzioux, P. Frange, A. Chéret, 2016, Clinical Microbiology Reviews.

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.

C. Rouzioux, P. Frange, Laurent Tran, 2015, The Journal of antimicrobial chemotherapy.

Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection.

C. Rouzioux, E. Abachin, S. Blanche, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-DNA in the Genital Tract of Women on Long-Term Effective Therapy Is Associated to Residual Viremia and Previous AIDS-Defining Illnesses

C. Rouzioux, A. Chaillon, L. Hocqueloux, 2013, PloS one.

Protease Inhibitor Resistance Analysis in the MONARK Trial Comparing First-Line Lopinavir-Ritonavir Monotherapy to Lopinavir-Ritonavir plus Zidovudine and Lamivudine Triple Therapy

C. Delaugerre, C. Rouzioux, F. Raffi, 2009, Antimicrobial Agents and Chemotherapy.

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients

Philippe Flandre, Pierre-Marie Girard, C. Delaugerre, 2008, AIDS.

Predictive Factors of Virologic Success in HIV-1–Infected Children Treated With Lopinavir/Ritonavir

C. Delaugerre, C. Rouzioux, S. Blanche, 2004, Journal of acquired immune deficiency syndromes.

Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children.

F. Dabis, C. Rouzioux, S. Blanche, 2003, Pediatrics.

Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda

C. Rouzioux, L. Pinoges, M. Pujades-Rodriguez, 2011, BMC pediatrics.

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

David A. Price, Brigitte Autran, Assia Samri, 2007, The Journal of experimental medicine.

New Sensitive One-Step Real-Time Duplex PCR Method for Group A and B HIV-2 RNA Load

C. Rouzioux, D. Descamps, M. Chaix, 2014, Journal of Clinical Microbiology.

One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection?

F. Brun-Vézinet, C. Rouzioux, D. Costagliola, 2008, AIDS.

Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).

R. Tubiana, C. Delaugerre, C. Rouzioux, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS.

F. Brun-Vézinet, P. Piot, H. Taelman, 1984, Science.

Hepatic Toxicity Associated with 2′-3'Dideoxyinosine in Children with AIDS

N. Brousse, C. Rouzioux, S. Blanche, 1995, Journal of pediatric gastroenterology and nutrition.

Prevalence and risk factors associated with antiretroviral resistance in HIV‐1‐infected children

C. Delaugerre, C. Rouzioux, S. Blanche, 2007, Journal of medical virology.

Perinatal HIV transmission facts and controversies.

C. Rouzioux, S. Blanche, J. Delfraissy, 1992, Immunodeficiency reviews.

Population Pharmacokinetic Modeling of Tenofovir in the Genital Tract of Male HIV-Infected Patients

C. Rouzioux, S. Urien, M. Suzan-Monti, 2016, Antimicrobial Agents and Chemotherapy.

HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens.

C. Rouzioux, D. Costagliola, B. Spire, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease

B. Masquelier, H. Fleury, C. Rouzioux, 1996 .

Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers.

C. Rouzioux, S. Blanche, F. Buseyne, 1998, AIDS research and human retroviruses.

Human immunodeficiency virus‐1 infection in neonates: correlation of plasma and cellular viremia and clinical outcome

C. Rouzioux, S. Blanche, M. Chaix, 1997 .

HIV proteins absent from placentas of 75 HIV-1-positive women studied by immunohistochemistry.

C. Rouzioux, M. Peuchmaur, J. Pons, 1991, AIDS.

Retrospective seroepidemiology of AIDS virus infection in Nairobi populations.

P. Piot, F. Plummer, C. Rouzioux, 1987, The Journal of infectious diseases.

TRANSPLACENTAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS

C. Rouzioux, D. Dormont, C. Courpotin, 1986, The Lancet.

Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay

F. Dabis, C. Rouzioux, P. Msellati, 2001, AIDS.

Apparent enhancement of perinatal transmission of human immunodeficiency virus type 1 by high maternal anti-gp160 antibody titer.

C. Rouzioux, D. Costagliola, T. Leste-Lasserre, 1998, The Journal of infectious diseases.

Drug-Free Remissions for HIV-Infected Individuals HIV Persistence and the Prospect of Long-Term

T. Chun, C. Rouzioux, D. Trono, 2010 .

Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction

H. Agut, C. Rouzioux, J. Huraux, 1992, Journal of clinical microbiology.

Field Evaluation of a Rapid Human Immunodeficiency Virus (HIV) Serial Serologic Testing Algorithm for Diagnosis and Differentiation of HIV Type 1 (HIV-1), HIV-2, and Dual HIV-1-HIV-2 Infections in West African Pregnant Women

F. Dabis, C. Rouzioux, D. Ekouevi, 2004, Journal of Clinical Microbiology.

Detection of HIV1 DNA in infants and children by means of the polymerase chain reaction.

C. Griscelli, C. Rouzioux, C. Bréchot, 1988, Lancet.

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression

Arsène Burny, Anna Kula, J. Gatot, 2015, PLoS pathogens.

Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.

C. Rouzioux, Y. Lévy, J. Lelièvre, 2009, The Journal of clinical investigation.

Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients

J. Gatot, C. Van Lint, C. Rouzioux, 2012, AIDS.

HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals

C. Van Lint, T. Chun, C. Rouzioux, 2010, Science.

Genotypic resistance profiles of HIV-2-treated patients in West Africa

C. Charpentier, F. Brun-Vézinet, F. Dabis, 2014, AIDS.

The Th17/Treg Ratio, IL-1RA and sCD14 Levels in Primary HIV Infection Predict the T-cell Activation Set Point in the Absence of Systemic Microbial Translocation

C. Rouzioux, D. Scott‐Algara, L. Meyer, 2013, PLoS pathogens.

Gene transfer of anti-gp41 antibody and CD4 immunoadhesin strongly reduces the HIV-1 load in humanized severe combined immunodeficient mice

C. Rouzioux, P. Leissner, M. Mehtali, 2000, AIDS.

A Novel Human Lymphotropic Retrovirus (LAV): New Data on Its Biology and Role in AIDS

J. Chermann, F. Barré-Sinoussi, C. Rouzioux, 1985 .

Novel Role of UHRF1 in DNA methylation-mediated repression of latent HIV-1

B. Berkhout, C. Rouzioux, F. Corazza, 2021, bioRxiv.

Towards an HIV cure: a global scientific strategy

M. Lederman, J. Mullins, A. Telenti, 2012, Nature Reviews Immunology.

HIV cure and eradication: how will we get from the laboratory to effective clinical trials?

S. Lewin, C. Rouzioux, 2011, AIDS.

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1

Anna Kula, J. Gatot, C. Van Lint, 2015, EMBO molecular medicine.

Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection

Arsène Burny, Dolores Vaira, J. Gatot, 2009, PloS one.

HIV-1 co-infection prevalence in two cohorts of early HIV-1 seroconverters in France

C. Rouzioux, L. Meyer, P. Van de Perre, 2007, AIDS.

Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load.

P. Debré, C. Rouzioux, Y. Nagai, 2002, The Journal of infectious diseases.

Lymphadenopathy syndrome in two thalassemic patients after LAV contamination by blood transfusion.

S. Chamaret, C. Rouzioux, L. Montagnier, 1985, The New England journal of medicine.

Gag-Specific CD8 T Cell Responses Cells from HIV Controllers: Association with Heterogeneity in HIV Suppression by CD8 T

C. Rouzioux, M. Sinet, J. Delfraissy, 2013 .

Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses1

C. Rouzioux, O. Lambotte, M. Sinet, 2009, The Journal of Immunology.

Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network

F. Brun-Vézinet, B. Masquelier, C. Rouzioux, 2007, Antiviral therapy.

Impact of HIV type 1 DNA levels on spontaneous disease progression: a meta-analysis.

P. Bagos, A. Hatzakis, C. Rouzioux, 2012, AIDS research and human retroviruses.

Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort.

C. Rouzioux, T. Allègre, L. Meyer, 2010, The Journal of antimicrobial chemotherapy.

Early Control of HIV-1 Infection in Long-Term Nonprogressors Followed Since Diagnosis in the ANRS SEROCO/HEMOCO Cohort

C. Rouzioux, L. Meyer, Y. Madec, 2009, Journal of acquired immune deficiency syndromes.

HIV-1 DNA in Peripheral Blood Mononuclear Cells Is Strongly Associated With HIV-1 Disease Progression in Recently Infected West African Adults

C. Rouzioux, A. Minga, X. Anglaret, 2008, Journal of acquired immune deficiency syndromes.

CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.

P. Morlat, C. Rouzioux, L. Meyer, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.

C. Rouzioux, L. Meyer, C. Goujard, 2005, The Journal of infectious diseases.

Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression.

H. Agut, B. Autran, P. Debré, 2005, The Journal of infectious diseases.

Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon?

C. Rouzioux, L. Meyer, Y. Madec, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection

C. Rouzioux, L. Meyer, C. Tamalet, 2000, AIDS.

Status of long‐term asymptomatic HIV‐1 infection correlates with viral load but not with virus replication properties and cell tropism

H. Agut, B. Autran, C. Rouzioux, 1999, Journal of medical virology.

Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/μL

C. Rouzioux, M. Chavance, L. Meyer, 1998 .

Longitudinal study of plasma HIV‐1 RNA concentrations during the asymptomatic stage of HIV infection measured using AMPLICOR HIV monitor and NASBA HIV‐1 RNA QT tests

C. Rouzioux, M. Chaix, C. Deveau, 1998, Journal of medical virology.

Examination of real-time PCR for HIV-1 RNA and DNA quantitation in patients infected with HIV-1 BF intersubtype recombinant variants.

H. Salomón, C. Rouzioux, G. Turk, 2007, Journal of virological methods.

Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome

C. Katlama, C. Rouzioux, B. Régnier, 1988, Digestive Diseases and Sciences.

Human cytomegalovirus (HCMV) short tandem repeats analysis in congenital infection.

Y. Ville, C. Rouzioux, M. Leruez-Ville, 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-α are potent inducers of HIV-specific CD8 T cells

C. Rouzioux, P. Langlade‐Demoyen, L. Weiss, 2003, AIDS.

Detailed analysis of the genetic evolution of influenza virus during the course of an epidemic

F. Carrat, P. Böelle, P. Boelle, 2005, Epidemiology and Infection.

Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France.

F. Carrat, A. Valleron, B. Housset, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner

Olivier Gascuel, Laurence Meyer, Sylvie Abel, 2013, PloS one.

First case of mother-to-infant HIV type 1 group O transmission and evolution of C2V3 sequences in the infected child. French HIV Pediatric Cohort Study Group.

C Chappey, C. Chappey, C. Rouzioux, 1998, AIDS research and human retroviruses.

Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France

F. Brun-Vézinet, B. Masquelier, C. Rouzioux, 2003, AIDS.

Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children.

C. Rouzioux, S. Blanche, F. Buseyne, 2002, The Journal of infectious diseases.

Optimal maturation of the SIV-specific CD8+ T-cell response after primary infection is associated with natural control of SIV. ANRS SIC study

C. Rouzioux, E. Gostick, Sian Llewellyn-Lacey, 2019, bioRxiv.

Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus control

W. Lu, A. Samri, B. Autran, 2010, AIDS.

Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.

C. Rouzioux, S. Blanche, F. Buseyne, 1998, Virology.

Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.

A. Samri, B. Autran, C. Rouzioux, 2015, The Journal of antimicrobial chemotherapy.

Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA.

C. Rouzioux, L. Meyer, C. Goujard, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.

C. Katlama, C. Rouzioux, F. Raffi, 2015, The Lancet. Infectious diseases.

Post-treatment Controllers

C. Rouzioux, A. Sáez-Cirión, L. Hocqueloux, 2014 .

A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection

C. Katlama, B. Autran, Y. Yazdanpanah, 2013, PloS one.

Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells.

G. Carcelain, A. Samri, B. Autran, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.

C. Rouzioux, L. Meyer, O. Lambotte, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study)

C. Rouzioux, O. Lambotte, A. Sáez-Cirión, 2007, AIDS.

T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection

C. Rouzioux, D. Costagliola, C. Didier, 2014, AIDS.

Greater diversity of HIV DNA variants in the rectum compared to variants in the blood in patients without HAART

C. Rouzioux, M. Müller-Trutwin, L. Hocqueloux, 2011, Journal of medical virology.

X4 Tropic Multi-Drug Resistant Quasi-Species Detected at the Time of Primary HIV-1 Infection Remain Exclusive or at Least Dominant Far from PHI

C. Rouzioux, J. Izopet, L. Meyer, 2011, PloS one.

Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients

C. Rouzioux, Y. Lévy, J. Guillet, 2005, AIDS.

CD8 T-Cells from Most HIV-Infected Patients Lack Ex Vivo HIV-Suppressive Capacity during Acute and Early Infection

C. Rouzioux, L. Meyer, A. Sáez-Cirión, 2013, PloS one.

Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02

C. Delaugerre, C. Rouzioux, L. Meyer, 2011, AIDS.

HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection

N. Paul, A. Samri, B. Autran, 2017, EBioMedicine.

Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men

Roland Tubiana, Franck Letourneur, Christine Katlama, 2004, AIDS.

HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time

C. Rouzioux, L. Meyer, C. Tamalet, 2006, AIDS.

Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome

R. Tubiana, C. Delaugerre, C. Rouzioux, 2009, Retrovirology.

French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002

F. Brun-Vézinet, P. André, B. Masquelier, 2005, Journal of acquired immune deficiency syndromes.

Recent changes in the management of primary HIV‐1 infection: results from the French PRIMO cohort

C. Rouzioux, V. Schiffer, L. Meyer, 2004, HIV medicine.

Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment.

C. Rouzioux, B. Hoen, L. Meyer, 2002, AIDS.

Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.

Y. Yazdanpanah, C. Rouzioux, P. Frange, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Spatiotemporal dynamics of HIV-1 transmission in France (1999–2014) and impact of targeted prevention strategies

C. Delaugerre, C. Rouzioux, Davey M. Smith, 2017, Retrovirology.

Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study

Brigitte Autran, Laurence Meyer, Asier Sáez-Cirión, 2013, PLoS pathogens.

HIV DNA: a clinical marker of HIV reservoirs

C. Rouzioux, P. Trémeaux, V. Avettand-Fenoël, 2018, Current opinion in HIV and AIDS.

Long-term Therapeutic Impact of the Timing of Antiretroviral Therapy in Patients Diagnosed With Primary Human Immunodeficiency Virus Type 1 Infection

P. Morlat, C. Rouzioux, L. Meyer, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Total HIV DNA: a global marker of HIV persistence

C. Rouzioux, V. Avettand-Fenoël, 2018, Retrovirology.

Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir

Anna Kula, C. Van Lint, C. Rouzioux, 2017, AIDS.

A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control

C. Rouzioux, D. Costagliola, P. Girard, 2015, AIDS.

Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection

Thierry Prazuck, C. Rouzioux, L. Hocqueloux, 2010, AIDS.

CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory

C. Rouzioux, L. Meyer, O. Lambotte, 2011, PloS one.

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983.

J. Chermann, F. Barré-Sinoussi, F. Rey, 2004, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

HIV-1 DNA for the measurement of the HIV reservoir is predictive of disease progression in seroconverters whatever the mode of result expression is.

C. Rouzioux, L. Meyer, J. Galimand, 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study.

C. Rouzioux, P. Frange, L. Meyer, 2009, The Journal of antimicrobial chemotherapy.

HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment.

M. Mouroux, V. Calvez, C. Rouzioux, 2000, AIDS research and human retroviruses.

Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d’Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort

C. Rouzioux, C. Amani-Bossé, N. Meda, 2017, Journal of the International AIDS Society.

HIV-1 DNA concentrations and evolution among African HIV-1-infected children under antiretroviral treatment (ANRS 1244/1278).

C. Rouzioux, P. Msellati, F. Rouet, 2014, The Journal of antimicrobial chemotherapy.

HIV viral load algorithm: what are the needs in the field?

Guillaume Breton, G Laborde-Balen, F Guilavogui, 2019, AIDS.

Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort.

C. Rouzioux, F. Monpoux, L. Meyer, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-1 quantification in infected children born to seropositive mothers.

C. Rouzioux, S. Blanche, A. Ferroni, 1993, AIDS (London).

Not All Tetramer Binding CD8+ T Cells Can Produce Cytokines and Chemokines Involved in the Effector Functions of Virus-Specific CD8+ T Lymphocytes in HIV-1 Infected Children

C. Rouzioux, D. Scott‐Algara, S. Blanche, 2005, Journal of Clinical Immunology.

Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1-infected infants

C. Rouzioux, F. Monpoux, C. Dollfus, 2002, The Pediatric infectious disease journal.

Posttreatment controllers: what do they tell us?

C. Rouzioux, A. Sáez-Cirión, L. Hocqueloux, 2015, Current opinion in HIV and AIDS.

The frequency of HIV-specific interferon- gamma -producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children.

C. Rouzioux, D. Scott‐Algara, S. Blanche, 2005, The Journal of infectious diseases.

Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996–2006 in France

C. Delaugerre, B. Masquelier, C. Rouzioux, 2009, AIDS.

Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.

C. Rouzioux, L. Hocqueloux, T. Prazuck, 2013, The Journal of antimicrobial chemotherapy.

In Untreated HIV-1–Infected Children, PBMC-Associated HIV DNA Levels and Cell-Free HIV RNA Levels Are Correlated to Distinct T-lymphocyte Populations

C. Rouzioux, D. Scott‐Algara, S. Blanche, 2010, Journal of acquired immune deficiency syndromes.

Zidovudine therapy in children with acquired immunodeficiency syndrome.

C. Griscelli, C. Rouzioux, G. Duhamel, 1988, The American journal of medicine.

Late postnatal HIV infection in children born to HIV-1-infected mothers in a high-income country

C. Rouzioux, P. Frange, C. Dollfus, 2010, AIDS.

Evaluation of dried blood spot diagnosis using HIV1-DNA and HIV1-RNA Biocentric assays in infants in Abidjan, Côte d'Ivoire. The Pedi-Test DBS ANRS 12183 Study.

C. Rouzioux, C. Amani-Bossé, V. Leroy, 2013, Journal of virological methods.

Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration

D. Minta, F. Dabis, C. Rouzioux, 2015, PloS one.

Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments

A. Burny, C. Van Lint, C. Rouzioux, 2019, Journal of acquired immune deficiency syndromes.

Polymorphism in Gag Gene Cleavage Sites of HIV-1 Non-B Subtype and Virological Outcome of a First-Line Lopinavir/Ritonavir Single Drug Regimen

C. Delaugerre, C. Rouzioux, F. Raffi, 2011, PloS one.

Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery

C. Rouzioux, N. Elenga, S. Tiendrebeogo, 2002 .

Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group.

B. Masquelier, C. Rouzioux, D. Dormont, 1996, JAMA.

Elite controllers as a model of functional cure

B. Autran, C. Rouzioux, B. Descours, 2011, Current opinion in HIV and AIDS.

Blood Epstein–Barr virus DNA load and risk of progression to AIDS‐related systemic B lymphoma

C. Rouzioux, L. Meyer, C. Goujard, 2012, HIV medicine.

Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS.

O. Delaneau, J. Goedert, J. Phair, 2010, The Journal of infectious diseases.

Timing of human immunodeficiency virus type 1 (HIV-1) transmission from mother to child: bayesian estimation using a mixture.

C. Rouzioux, D. Costagliola, S. Blanche, 1999, Statistics in medicine.

POSSIBLE TRANSMISSION OF A HUMAN LYMPHOTROPIC RETROVIRUS (LAV) FROM MOTHER TO INFANT WITH AIDS

A. Fischer, V. Vié, F. Brun-Vézinet, 1984, The Lancet.

No evidence of a change in HIV-1 virulence since 1996 in France

C. Rouzioux, Laurent Tran, L. Meyer, 2009, AIDS (London).

Previous Antiretroviral Therapy for Prevention of Mother-to-Child Transmission of HIV Does not Hamper the Initial Response to PI-Based Multitherapy During Subsequent Pregnancy

R. Tubiana, C. Rouzioux, L. Mandelbrot, 2011, Journal of acquired immune deficiency syndromes.

Characteristics of HIV-infected children recently diagnosed in Paris, France

C. Picard, C. Rouzioux, B. Neven, 2006, European Journal of Pediatrics.

Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.

R. Tubiana, C. Rouzioux, L. Mandelbrot, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Does pregnancy affect the early response to cART?

R. Tubiana, C. Rouzioux, A. Rachas, 2013, AIDS.

Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohort.

B. Masquelier, H. Fleury, C. Rouzioux, 2001 .

Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state.

F. Brun-Vézinet, J. Chermann, F. Barré-Sinoussi, 1984, The New England journal of medicine.

Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Specific CD8+ T Cell Response in HIV Controllers

C. Rouzioux, L. Meyer, O. Lambotte, 2013, Journal of Virology.

Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?

A. Fischer, R. Tubiana, L. Cravello, 2020, The Journal of antimicrobial chemotherapy.

[HIV and pregnancy: 2013 guidelines from the French expert working group].

A. Berrebi, R. Tubiana, P. Morlat, 2014, Journal de gynecologie, obstetrique et biologie de la reproduction.

Alpha interferon administration during structured interruptions of combination antiretroviral therapy in patients with chronic HIV-1 infection: INTERVAC ANRS 105 trial

C. Rouzioux, D. Costagliola, C. Goujard, 2011, AIDS.

Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression.

C. Rouzioux, J. Guillet, M. Dalod, 1996, AIDS research and human retroviruses.

A vaccinia-based elispot assay for detection of CD8+ T cells from HIV-1 infected children.

C. Rouzioux, D. Scott‐Algara, S. Blanche, 2005, Journal of immunological methods.

HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression.

H. Agut, B. Autran, C. Rouzioux, 2001, AIDS research and human retroviruses.

Acquired immunodeficiency syndrome (AIDS) in Africans.

F. Brun-Vézinet, C. Katlama, C. Rouzioux, 1984, Annales de la Societe belge de medecine tropicale.

Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients

C. Rouzioux, J. Izopet, J. Seigneurin, 2009, AIDS.

The lymphocyte HIV reservoir in patients on long-term HAART is a memory of virus evolution

Yassine Taoufik, C. Rouzioux, O. Lambotte, 2004, AIDS.

Interlaboratory quality control of total HIV‐1 DNA load measurement for multicenter reservoir studies

C. Delaugerre, C. Rouzioux, K. Sauné, 2017, Journal of medical virology.

OP 2.6 – 00135 Constitutive NKG2A levels and timing of antiretroviral therapy initiation impact the potential role of NK cells after treatment interruption - the pVISCONTI study

C. Rouzioux, M. Müller-Trutwin, C. Passaes, 2022, Journal of virus eradication.

HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors

C. Rouzioux, L. Hocqueloux, V. Avettand-Fenoel, 2008, AIDS.

Failure of bone marrow transplantation to eradicate HIV reservoir despite efficient HAART.

C. Rouzioux, M. Cavazzana‐Calvo, N. Mahlaoui, 2007, AIDS.

What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM

P. André, G. Carcelain, A. Samri, 2017, EBioMedicine.

Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation

C. Van Lint, J. Martinez-Picado, J. Prado, 2015, Journal of Virology.

Higher HIV-1 DNA associated with lower gains in CD4 cell count among patients with advanced therapeutic failure receiving optimized treatment (ANRS 123--ETOILE).

C. Fagard, C. Rouzioux, G. Chêne, 2010, The Journal of antimicrobial chemotherapy.

Impact of 48 week lopinavir/ritonavir monotherapy on blood cell-associated HIV-1-DNA in the MONARK trial.

C. Delaugerre, C. Rouzioux, F. Raffi, 2010, The Journal of antimicrobial chemotherapy.

Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level

C. Rouzioux, C. Rothschild, C. Rabian, 2003, AIDS.

Frequencies of Ex Vivo-Activated Human Immunodeficiency Virus Type 1-Specific Gamma-Interferon-Producing CD8+ T Cells in Infected Children Correlate Positively with Plasma Viral Load

C. Rouzioux, D. Scott‐Algara, S. Blanche, 2002, Journal of Virology.

, with Plasma Viral Load in Infected Children Correlate Positively T Cells + Gamma-Interferon-Producing CD 8 Immunodeficiency Virus Type 1-Specific Frequencies of Ex Vivo-Activated Human

C. Rouzioux, D. Scott‐Algara, S. Blanche, 2002 .

Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV

P. Morlat, C. Rouzioux, Y. Lévy, 2012, AIDS.

Interruption of antiretroviral therapy initiated during primary HIV-1 infection: impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 Randomized Study.

C. Rouzioux, Y. Lévy, R. El Habib, 2007, AIDS research and human retroviruses.

Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial

É. Oksenhendler, C. Rouzioux, Y. Lévy, 2003, AIDS.

Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients.

C. Rouzioux, Y. Lévy, J. Delfraissy, 2001, AIDS.

Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers.

C. Rouzioux, D. Scott‐Algara, S. Blanche, 2001, The Journal of infectious diseases.

Patient-Specific Cytotoxic T-Lymphocyte Cross-Recognition of Naturally Occurring Variants of a Human Immunodeficiency Virus Type 1 (HIV-1) p24gagEpitope by HIV-1-Infected Children

C. Rouzioux, S. Blanche, F. Buseyne, 2001, Journal of Virology.

Patient-Speciﬁc Cytotoxic T-Lymphocyte Cross-Recognition of Naturally Occurring Variants of a Human Immunodeﬁciency Virus Type 1 (HIV-1) p24 gag Epitope by HIV-1-Infected Children

C. Rouzioux, S. Blanche, F. Buseyne, 2001 .

Long-term follow-up of 120 patients with AIDS-related Kaposi's sarcoma treated with interferon alpha-2a.

C. Rouzioux, W. Rozenbaum, S. Gharakhanian, 1990, The Journal of investigative dermatology.

Contributions CCR 5 Chemokine Receptor Variant in HIV-1 Mother-to-Child Transmission and Disease Progression in Children

C. Rouzioux, S. Blanche, J. Delfraissy, 2001 .

Cot death and myocarditis

N. Brousse, C. Rouzioux, C. Cieuta, 1992, Cardiology in the Young.

[Sudden crib death. Experience in a referral center 1986-1991].

N. Brousse, C. Rouzioux, G. Chéron, 1993, Archives francaises de pediatrie.

Prevalence and Clinical Impact of Norovirus Fecal Shedding in Children with Inherited Immune De fi ciencies

A. Fischer, C. Rouzioux, P. Frange, 2012 .

Short communication: evidence of HIV type 1 complex and second generation recombinant strains among patients infected in 1997-2007 in France: ANRS CO06 PRIMO Cohort.

C. Rouzioux, P. Frange, L. Meyer, 2010, AIDS research and human retroviruses.

HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimens.

C. Rouzioux, D. Costagliola, M. Suzan-Monti, 2016, The Journal of antimicrobial chemotherapy.

False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.

É. Oksenhendler, C. Katlama, D. Neau, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunological and virological features of HIV‐infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor‐based therapy

C. Rouzioux, M. Kazatchkine, J. Gilquin, 2002, HIV medicine.

Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF.

C. Delaugerre, C. Rouzioux, G. Peytavin, 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[Pediatric aids, 30 years later].

R. Tubiana, C. Rouzioux, L. Mandelbrot, 2013, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Lymphadenopathy associated virus and its etiological role in AIDS.

F. Brun-Vézinet, J. Chermann, S. Wain-Hobson, 1984, Princess Takamatsu symposia.

Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers

Y. Yazdanpanah, C. Rouzioux, H. Mouquet, 2022, Nature Communications.

Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2018, The Journal of antimicrobial chemotherapy.

Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant

C. Rouzioux, R. Sperling, R. Coombs, 1997 .

Elite and viremic HIV-1 controllers in West Africa

C. Rouzioux, O. Lambotte, S. Eholie, 2021, AIDS.

How much would the safety of blood transfusion be improved by including p24 antigen in the battery of tests?

A. Valleron, C. Rouzioux, D. Costagliola, 1995, Transfusion.

Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS.

F. Brun-Vézinet, J. Chermann, F. Barré-Sinoussi, 1985, JAMA.

Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome.

F. Brun-Vézinet, J. Lifson, J. Chermann, 1985, Annals of internal medicine.

Impact of Counseling Methods on HIV Retesting Uptake in At-Risk Individuals: A Randomized Controlled Study

S. Chevret, C. Rouzioux, J. Mary, 2019, AIDS and Behavior.

Direct HIV testing in blood donations: variation of the yield with detection threshold and pool size

H C Tuckwell, D Costagliola, H. Tuckwell, 1999, Transfusion.

A guinea pig model for cytomegalovirus congenital infection: dose-effect and vertical transmission rate

Y. Ville, C. Rouzioux, G. Benoist, 2008, Retrovirology.

Association of Plasma sVCAM-1 and sCD14 with Mortality in HIV-1 Infected West African Adults with High CD4 Counts

C. Rouzioux, S. Eholie, C. Dunyach-Rémy, 2020, SSRN Electronic Journal.

Dynamics in HIV‐DNA levels over time in HIV controllers

B. Autran, C. Rouzioux, L. Meyer, 2019, Journal of the International AIDS Society.

Human immunodeficiency virus-1 infection in neonates: correlation of plasma and cellular viremia and clinical outcome. French Pediatric Cohort Study Group.

C. Rouzioux, S. Blanche, M. Chaix, 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.

6-month eff i c a c y, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d’Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial

R. Salamon, F. Dabis, C. Rouzioux, 1999 .

Prognostic factors for virological response in antiretroviral therapy-naive patients in the MONARK Trial randomized to ritonavir-boosted lopinavir alone

A. Gładysz, C. Delaugerre, C. Rouzioux, 2009, Antiviral therapy.

In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control

O. Gascuel, C. Rouzioux, O. Lambotte, 2023, Microbiology spectrum.

Pe rsistent mitochondrial dysfunction and perinatal exposure to a n t i r e t r oviral nucleoside analogues

C. Lacroix, C. Rouzioux, L. Mandelbrot, 1999 .

Hiv-1 Control after Transient Antiretroviral Treatment Initiated in Primary Infection: Role of Patient Characteristics and Effect of Therapy

C. Rouzioux, L. Meyer, M. Sinet, 2012, Antiviral therapy.

Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial.

P. Morlat, C. Rouzioux, L. Meyer, 2022, The Journal of antimicrobial chemotherapy.

Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression.

C. Fagard, C. Rouzioux, F. Raffi, 2016, The Journal of antimicrobial chemotherapy.

Low Frequency of CXCR4-Using Viruses in Patients at the Time of Primary Non-Subtype-B HIV-1 Infection

C. Rouzioux, J. Izopet, P. Frange, 2010, Journal of Clinical Microbiology.

Prevalence of CXCR4-tropic viruses in clustered transmission chains at the time of primary HIV-1 infection.

R. Tubiana, C. Rouzioux, P. Frange, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

New and old complex recombinant HIV-1 strains among patients with primary infection in 1996–2006 in France: The French ANRS CO06 primo cohort study

M. Peeters, C. Rouzioux, P. Frange, 2008, Retrovirology.

Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: impact of age.

C. Rouzioux, D. Scott‐Algara, S. Blanche, 2006, Virology.

Structured Treatment Interruptions in Primary HIV-1 Infection: The ANRS 100 PRIMSTOP Trial

C. Rouzioux, B. Hoen, F. Raffi, 2005, Journal of acquired immune deficiency syndromes.

In HIV type 1-infected children cytotoxic T lymphocyte responses are associated with greater reduction of viremia under antiretroviral therapy.

C. Rouzioux, S. Blanche, F. Buseyne, 2005, AIDS research and human retroviruses.

Impact of highly active antiretroviral therapy on the maturation of anti‐HIV‐1 antibodies during primary HIV‐1 infection

C. Rouzioux, L. Meyer, C. Goujard, 2006, HIV medicine.

Biotechnology in the Development of HIV Diagnostic Procedures

C. Rouzioux, 1988 .

Correction: How much would the safety of blood transfusion be improved by including p24 antigen in the battery of tests?

A. Valleron, C. Rouzioux, D. Costagliola, 1995, Transfusion.

Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy

C. Rouzioux, L. Meyer, M. Sinet, 2001, AIDS.

Spatiotemporal dynamics of HIV-1 transmission in France (1999–2014) and impact of targeted prevention strategies

C. Delaugerre, C. Rouzioux, Davey M. Smith, 2017, Retrovirology.

Recent HIV-1 Infection Contributes to the Viral Diffusion over the French Territory with a Recent Increasing Frequency

P. Morlat, C. Rouzioux, P. Frange, 2012, PloS one.

Relationship between Regulatory T Cells and Immune Activation in Human Immunodeficiency Virus-Infected Patients Interrupting Antiretroviral Therapy

C. Rouzioux, D. Costagliola, Y. Lévy, 2010, PloS one.

Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.

Marc Dalod, Laurence Meyer, Alejandra Urrutia, 2003, The Journal of infectious diseases.

Causal Pathways of the Effects of Age and the CCR5-Δ32, CCR2-64I, and SDF-1 3′A Alleles on AIDS Development

B. Berkhout, H. Schuitemaker, R. Geskus, 2005, Journal of acquired immune deficiency syndromes.

Characteristics of the env Genes of HIV Type 1 Quasispecies in Long-Term Nonprogressors With Broadly Neutralizing Antibodies

H. Agut, B. Autran, C. Rouzioux, 2008, Journal of acquired immune deficiency syndromes.

Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity

H. Katinger, H. Agut, B. Autran, 2006, AIDS.

Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma.

F. Barré-Sinoussi, C. Rouzioux, J. Bach, 1992, The Journal of infectious diseases.

New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification

C. Rouzioux, F. Collin, D. Descamps, 2017, Journal of Clinical Microbiology.

Residual HIV-1 replication may impact immune recovery in patients on first-line lopinavir/ritonavir monotherapy.

C. Rouzioux, J. Delfraissy, T. Tran, 2015, Journal of Antimicrobial Chemotherapy.

Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.

C. Rouzioux, F. Raffi, J. Bresson, 2008, The Journal of antimicrobial chemotherapy.

Genital Human Immunodeficiency Virus-1 RNA and DNA Shedding in Virologically Suppressed Individuals Switching From Triple- to Dual- or Monotherapy: Pooled Results From 2 Randomized, Controlled Trials.

C. Rouzioux, L. Hocqueloux, T. Prazuck, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012).

C. Rouzioux, P. Jouannet, B. Silbermann, 2002, AIDS.

Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group.

H. Agut, B. Autran, C. Rouzioux, 1999 .

[Acquired immunodeficiency syndrome in 4 homosexuals].

C. Rouzioux, W. Rozenbaum, D. Klatzmann, 1983, Presse medicale.

Polyfunctional HIV-specific T cells in Post-Treatment Controllers.

A. Samri, B. Autran, C. Rouzioux, 2016, AIDS.

Cytomegalovirus infection in HIV-infected versus non-infected infants and HIV disease progression in Cytomegalovirus infected versus non infected infants early treated with cART in the ANRS 12140—Pediacam study in Cameroon

C. Rouzioux, J. Warszawski, A. Faye, 2017, BMC Infectious Diseases.

Estimation of HIV-1 DNA Level Interfering with Reliability of HIV-1 RNA Quantification Performed on Dried Blood Spots Collected from Successfully Treated Patients

C. Rouzioux, N. Meda, T. Kagoné, 2016, Journal of Clinical Microbiology.

Use of Reverse Transcription-PCR-Based Assays for Quantification of HIV-1 in Dried Blood Spots Requires Specific HIV-1 RNA Isolation for Monitoring of Antiretroviral Treatment Efficiency

C. Rouzioux, D. Descamps, F. Rouet, 2014, Journal of Clinical Microbiology.

Seronegativation in Early Treated HIV-Infected Infants: Frequency and Potential Implications on Care and Follow-up in a Resource-Limited Country

P. Boisier, C. Rouzioux, J. Warszawski, 2011, Journal of acquired immune deficiency syndromes.

Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France.

M. Peeters, E. Delaporte, C. Rouzioux, 2008, AIDS research and human retroviruses.

Increasing contribution of integrated forms to total HIV DNA in blood during HIV disease progression from primary infection

C. Rouzioux, O. Delelis, L. Meyer, 2019, EBioMedicine.

Decreased peripheral circulation of HIV-infected cells in a subset of long-term nonprogressors. The French ALT Study Group.

V. Calvez, H. Agut, B. Autran, 1999, Journal of acquired immune deficiency syndromes.

Gag-Specific CD4 T Cell Proliferation, Plasmacytoid Dendritic Cells, and Ethnicity in Perinatally HIV-1-Infected Youths: The ANRS-EP38-IMMIP Study.

C. Rouzioux, D. Scott‐Algara, T. Montange, 2016, AIDS research and human retroviruses.

Gag-specific CD4 T-cell proliferation, plasmacytoid dendritic cells and ethnicityin perinatally HIV-1-infected youths – The ANRS-EP38-IMMIP Study Short title: T-cell proliferation and dendritic cells

C. Rouzioux, D. Scott‐Algara, T. Montange, 2020 .

Gag-specific CD 4 T-cell proliferation , plasmacytoid dendritic cells and ethnicityin perinatally HIV-1-infected youths – The ANRS-EP 38-IMMIP Study Short title : T-cell proliferation and dendritic cells

C. Rouzioux, D. Scott‐Algara, T. Montange, 2019 .

Rapid CD4+ Cell Decrease After Transient cART Initiated During Primary HIV Infection (ANRS PRIMO and SEROCO Cohorts)

C. Rouzioux, L. Meyer, M. Sinet, 2008, Journal of acquired immune deficiency syndromes.

[Reproductive options for people living with HIV: 2013 guidelines from the French expert working group].

A. Berrebi, R. Tubiana, P. Morlat, 2014, Gynecologie, obstetrique & fertilite.

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007 – 12: impact on susceptibility to ﬁrst-line strategies

C. Rouzioux, P. Frange, Laurent Tran, 2015 .

High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy.

C. Rouzioux, D. Costagliola, J. Viard, 1998, AIDS.

Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.

C. Rouzioux, W. Rozenbaum, D. Guétard, 1989, AIDS.

Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.

J. Lifson, J. Chermann, S. West, 1985, Annals of internal medicine.

Primary HIV-1 infection in African children infected through breastfeeding

F. Dabis, C. Rouzioux, N. Elenga, 2002, AIDS.

Tolerance and viral resistance after single-dose nevirapine (NVP) and short-course of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) to prevent mother-to-child transmission (PMTCT) of HIV-1: the TEmAA ANRS 12109 phase II trial, step 1

F. Dabis, C. Rouzioux, G. Gray, 2008, Retrovirology.

[Survival of the human immunodeficiency virus (HIV-1) in Triatoma infestans (Klug, 1834)].

C. Rouzioux, C. Romaña, W. Lowenstein, 1992, Bulletin de la Société de Pathologie Exotique.

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2019, BMC Infectious Diseases.

Relationship between Regulatory T Cells and Immune Activation in Human Immunodeficiency Virus-Infected Patients Interrupting Antiretroviral Therapy

C. Rouzioux, D. Costagliola, Y. Lévy, 2010, PloS one.

Exon 4 of the Human Cytomegalovirus (CMV) Major Immediate-Early Gene as a Target for CMV Real-Time PCR

C. Rouzioux, M. Leruez-Ville, A. Ducroux, 2008, Journal of Clinical Microbiology.

HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French Pediatric Cohort ANRS EPF-CO10. A case report.

C. Rouzioux, P. Frange, C. Dollfus, 2016 .

LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01).

C. Rouzioux, S. Blanche, J. Warszawski, 2009, Journal of Medical Virology.

Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity — The ANRS-EP38-IMMIP Study

C. Rouzioux, D. Scott‐Algara, T. Montange, 2015, PloS one.

Factors associated with being overweight and obesity in people living with HIV on antiretroviral therapy : socio-clinical, inflammation, and metabolic markers.

A. Maignan, Y. Yazdanpanah, D. Neau, 2021, The Journal of infectious diseases.

No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study.

C. Katlama, Y. Yazdanpanah, E. Delaporte, 2021, Journal of Antimicrobial Chemotherapy.

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy

V. Calvez, G. Carcelain, R. Tubiana, 2010, AIDS.

No evidence for proliferation in the blood CD4+ T‐cell pool during HIV‐1 infection and triple combination therapy

C. Rouzioux, O. Tissot, C. Rabian, 1998, AIDS.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

R. Salamon, H. Ahiboh, C. Rouzioux, 2015, The New England journal of medicine.

Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study.

C. Rouzioux, D. Scott‐Algara, T. Montange, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influenza burden of illness: estimates from a national prospective survey of household contacts in France.

F. Carrat, B. Housset, C. Rouzioux, 2002, Archives of internal medicine.

No evidence of a change in HIV-1 virulence since 1996 in France

C. Rouzioux, Laurent Tran, L. Meyer, 2009, AIDS.

C. Rouzioux, P. Frange, G. Peytavin, 2016, The lancet. HIV.

The Kidney as a Reservoir for HIV-1 after Renal Transplantation

C. Rouzioux, O. Gribouval, G. Canaud, 2014 .

The Kidney as a Reservoir for HIV-1 after Renal Transplantation

C. Rouzioux, O. Gribouval, G. Canaud, 2014 .

The Kidney as a Reservoir for HIV-1 after Renal Transplantation

C. Rouzioux, O. Gribouval, G. Canaud, 2014 .

Influenza burden of illness: estimates from a national prospective survey of household contacts in France.